151 International Survey on the Management of Allergic Rhinitis by Physicians and Patients (ISMAR) (original) (raw)
Related papers
World Allergy Organization Journal, 2012
Epidemiologic studies suggest that the prevalence of allergic rhinitis (AR) is rising worldwide. Several reports, in fact, indicate increasing trends in the prevalence of AR especially in developing countries, likely related to the environment and climate changes and the adoption of an urbanized Western lifestyle. The primary objective of the present study was to collect information about management in real-life settings, including a characterization of typical patients' profile referring to physicians, the disease features, the common approaches to diagnostic assessments and therapeutic decisions. This was an international, multicenter, cross-sectional study conducted in adults or children (≥6 years) suffering from rhinitis confirmed by physician's diagnosis for at least one year. The 234 physicians who participated in the study included a total of 2778 patients in Egypt,
The international survey on the management of allergic rhinitis by physicians and patients (ISMAR)
World Allergy Organization Journal, 2015
Epidemiologic studies suggest that the prevalence of allergic rhinitis (AR) is rising worldwide. Several reports, in fact, indicate increasing trends in the prevalence of AR especially in developing countries, likely related to the environment and climate changes and the adoption of an urbanized Western lifestyle. The primary objective of the present study was to collect information about management in real-life settings, including a characterization of typical patients' profile referring to physicians, the disease features, the common approaches to diagnostic assessments and therapeutic decisions. This was an international, multicenter, cross-sectional study conducted in adults or children (≥6 years) suffering from rhinitis confirmed by physician's diagnosis for at least one year. The 234 physicians who participated in the study included a total of 2778 patients in Egypt, Mexico, Brazil, Colombia, Guatemala, Iran, Venezuela, Argentina, Israel, Kuwait and United Arab Emirates. It was found that clinical history was the selected tool to diagnose and categorize AR patients (97.1%), with less than half of patients undergoing allergy testing, may be explaining the scarce use of immunotherapy on management of disease. Out of 2776 patients, 93.4% had somehow received a recommendation to avoid allergens and irritant agent exposure. Notably, 91.4% were receiving at least one treatment at the time of the survey, mostly oral antihistamines (79.7%) and intranasal corticosteroids (66.3%). Oral antihistamines, intranasal steroids and decongestants were considered both safe and effective by patients and physicians, preferring oral and nasal route of administration. The ISMAR registry was designed according to the most accepted epidemiological recommendations, and provides interesting information regarding the management of rhinitis from a patient and physician points of view, with many similarities between the participating countries. Further efforts are required to better manage AR and its comorbidities.
The International Study of the Allergic Rhinitis Survey: outcomes from 4 geographical regions
Asia Pacific allergy, 2018
Allergic rhinitis (AR) is a global health problem and is characterised by one or more symptoms, including sneezing, itching, nasal congestion and rhinorrhea. We investigated the features of AR and the physician's approach to the management of AR patients in four geographical regions. In this cross-sectional study, a questionnaire survey concerning AR was completed by Honorary and Corresponding Members of the Italian Society of Rhinology from different countries among 4 world geographical regions-Asia, Europe, the Americas, and Africa. The prevalence of AR was reported to be 15%-25%. Children and adolescents, as well as young adults, were the age groups more affected by AR with comorbidities of asthma, sinusitis, conjunctivitis, and nasal polyposis. Nasal symptoms of AR were more intense in the spring (51.92%) and autumn (28.85%). The most common aero-allergens were pollen and mites (67.31%), animal dander and pollutants (23.08%), and fungal allergens (21.15%). Allergen-specific ...
2005
The goal: to assess the attitude of otorhinolaryngologists towards the allergic rhinitis. The objectives: to assess the attitude of otorhinolaryngologists towards the prevalence of allergic rhinitis in Armenia, it's impact on the health and on the quality of life of the patient, it's complications and possible preventive methods; to assess the current treatment strategies including the collaboration with allergists and the follow-up; and to find out the possible barriers to get proper treatment. Design: qualitative study, in-depth interviews. Setting: the otorhinolaryngological departments of four hospitals and four district policlinics in Yereven. Participants: 21 otorhinolaryngologists. Results: The participants were concerned about the increasing prevalence of allergic rhinitis in Armenia. However, there was a misunderstanding in distinguishing between allergic and nonallergic rhinitis affecting the quality of the treatment. The majority considered allergic rhinitis not a severe disease. There was no consistency in the treatment strategies and none knew about any guideline. The major concern for the treatment was the financial affordability of patients. Lack of finance was considered the main potential barrier for the first visits, and patient's awareness and the education level were defined as the key factors for the follow-up visits to the physician. Conclusion: Financial affordability of patients restricted the practical abilities of otorhinolaryngologists in treatment of allergic rhinitis and impacted on the quality of the treatment. The unavailability of recent literature and internet resources for the majority of specialists resulted in a lack of appropriate knowledge and attitude toward the allergic rhinitis. Nonetheless, adopting the existing WHO guidelines for low income countries could help to improve the quality of care of allergic rhinitis and to encourage continuing education among the specialists.
“Diagnostic and Treatment Outcome of Allergic Rhinitis: A Prospective clinical study”
2020
Background: Allergic Rhinitis is one of the commonest atopic diseases with greater morbidity and significant social and economic burden. The Allergic rhinitis and its impact on asthma (ARIA) group proposed a new classification based on the duration and severity of symptoms. Objective: To determine the diagnostic and treatment outcome of allergic rhinitispatients. Methods: This was a Prospective clinical study included 100 patients with a clinical diagnosis of allergic rhinitis in the Dept. of Otolaryngology-Head and Neck Surgery,Combined Military Hospital and Central Medical Board, Dhaka Cantonment, Bangladesh during from 1st September 2018 to 31th August 2019. Patients with clinical diagnosis of allergic rhinitis presented with two or more nasal symptoms of excessive sneezing, watery nasal discharge, nasal congestion and itching of nose and eyes in all age group and sex were taken in study. According to severity, the patients were divided into the mild groups and the moderate-sever...
International Primary Care Respiratory Group (IPCRG) Guidelines: Management of allergic rhinitis
The association between the upper and lower airways has been recognised for almost 2000 years. Epidemiological data suggest that most asthma patients also suffer from allergic rhinitis, and that both diseases share similar trigger factors and pathophysiology. This IPCRG Guideline on the management of rhinitis in primary care is fully consistent with the ARIA guidelines. It highlights the treatment goals and the classification of the condition according to symptom frequency (intermittent or persistent) and severity (mild or moderate-severe). It covers the need for allergen avoidance, pharmacologic therapy including immunotherapy, alternative therapies, management of ocular symptoms, the management of co-existing allergic rhinitis and asthma, and the need for follow-up and ongoing care for patients with rhinitis.
Physicians perception in the management of allergic rhinitis: a Pan-India survey
International Journal of Otorhinolaryngology and Head and Neck Surgery, 2020
Allergic rhinitis (AR) is a heterogeneous disorder affecting a wide proportion of the population in all age groups. This is an unpleasant and debilitating disorder with lifelong remissions and relapses. Epidemiological studies suggest that the incidence of allergic rhinitis is rising worldwide; it is recorded in around 10%-30% of adults and up to 40% of children worldwide. While considered trivial in India, 75 percent of children and 80 percent of adults with asthma reported AR. Symptoms may occur in some patients throughout the year, or in others during particular periods of the year. It not only affects person's quality of life, but often affects the ability of the person to work, frequently contributing to lose or unproductive time at work and at school and is often associated with sleep disturbances.
Management of allergic and non-allergic rhinitis: a primary care summary of the BSACI guideline
2010
Rhinitis is a common problem in primary care which is often managed sub-optimally. It causes considerable morbidity and has been shown to have a detrimental impact on people's ability to concentrate at school and at work. Rhinitis and asthma often present together, and symptomatic rhinitis can be associated with poor asthma control and increased risk of exacerbations. There is therefore a clear need to recognise and treat rhinitis according to guideline recommendations.